The second green band was collected and the solvent
removed to give 12-nitro-5,10,15,20-tetrakis(3,5-di-tert-butyl-
phenyl)bisquinoxalino[2,3-b0:7,8-b00]porphyrin 14b (366 mg,
63%) as a green microcrystalline solid, mp 4 300 1C. An
analytically pure sample was obtained by recrystallisation
(CH2Cl2–MeOH); (Found: C, 78.59; H, 7.43; N, 9.40.
C88H97N9O2 + 2CH3OH requires C, 78.51; H, 7.69; N,
9.16%); (HR-ESI-FT/ICR found: [M + H]+ 1312.7845.
C88H98N9O2 requires 1312.7838); nmax(CHCl3)/cmꢂ1 3326w
(NH), 3026s, 3014w, 2864s, 1524w (NO2), 1363m (NO2);
collected to give 5,10,15,20-tetrakis(3,5-di-tert-butylphenyl)-
trisquinoxalino[2,3-b0:7,8-b00:12,13-b0 00]porphyrin 1 (0.398 g,
64%) as a green microcrystalline solid, mp 4 300 1C. An
analytically pure sample was obtained by recrystallisation
(CHCl3–MeOH); (Found: C, 81.42; H, 7.48; N, 9.93.
C94H100N10 + CH3OH requires C, 81.39; H, 7.48; N,
9.99%); (ESI-HRMS found: [M
+
H]+ 1369.816.
C94H101N10 requires 1369.821); nmax(CHCl3)/cmꢂ1 3346w
(NH), 2962s, 2926s, 2856s, 1595s, 1576w, 1558w, 1545w,
1516w, 1506w, 1495w, 1487w, 1475m, 1466m, 1431w, 1393w,
1362s, 1352m, 1300m, 1248m, 1236m, 1204w, 1190w, 1173w,
1153m, 1136w, 1111s; lmax(CHCl3)/nm 307sh (loge 4.36), 345
(4.59), 390sh (4.71), 421 (4.87), 466 (4.83), 492 (4.94), 537sh
(3.98), 576 (4.15), 608 (4.18), 629sh (4.00), 638 (4.01), 687
(3.30); dH(400 MHz; CDCl3; 300 K) ꢂ0.44 (1 H, br s, inner
NH), ꢂ0.36 (1 H, br s, inner NH), 1.46 (36 H, s, t-butyl H),
1.49 (36 H, s, t-butyl H), 7.71–7.75 (4 H, m, quinoxaline H),
7.77–7.80 (2 H, m, quinoxaline H), 7.82–7.85 (2 H, m,
quinoxaline H), 7.87–7.89 (2 H, m, quinoxaline H), 7.89
(4 H, d, J 1.6 Hz, Ho), 7.92 (2 H, t, J 1.7 Hz, Hp), 7.94 (4 H,
d, J 1.6 Hz, Ho), 7.95–7.99 (2 H, m, quinoxaline H), 8.02 (2 H,
t, J 1.7 Hz, Ho), 8.76 (2 H, s, b-pyrrolic H); dH(400 MHz;
CDCl3; 230 K) ꢂ0.59 (1 H, s, inner NH), ꢂ0.52 (1 H, br s,
inner NH), 1.40 (36 H, s, t-butyl H), 1.45 (36 H, s, t-butyl H),
7.76–7.80 (8 H, m, quinoxaline H), 7.88–7.95 (16 H, m,
quinoxaline H, Ho, Hp), 8.82 (2 H, d, J 1.6 Hz, b-pyrrolic H);
m/z (ESI) 1369.9 ([M + H]+ requires 1369.8).
l
max(CHCl3)/nm 314sh (log e 4.46), 342 (4.57), 385sh (4.56),
421 (4.75), 455sh (4.89), 477 (5.06), 560 (4.10), 599 (4.14), 626
(4.07), 682 (3.77); dH(400 MHz; CDCl3) ꢂ0.29 (2 H, br s, inner
NH), 1.45 (18 H, s, t-butyl H), 1.48 (36 H, s, t-butyl H), 1.54
(18 H, s, t-butyl H), 7.74–7.78 (3 H, m, quinoxaline H, Hp),
7.82–7.88 (5 H, m, quinoxaline H, aryl H), 7.89 (2 H, d,
J 1.8 Hz, Ho), 7.91–7.94 (5 H, m, quinoxaline H, Ho, Hp), 7.98
(2 H, d, J 1.7 Hz, Ho), 8.01 (1 H, t, J 1.8 Hz, Hp), 8.03 (2 H, d,
J 1.9 Hz, Hp), 8.68 and 8.70 (2 H, ABq, J 4.8 Hz, b-pyrrolic
H), 8.78 (1 H, s, b-pyrrolic H); m/z (ESI) 1312.9 ([M + H]+
requires 1312.8).
Method 2: demetallation of copper(II) corner 12- and
13-nitro-bisquinoxalinoporphyrin 13. A solution of {12- and
13-nitro-5,10,15,20-tetrakis(3,5-di-tert-butylphenyl)bisquinoxalino-
[2,3-b0:7,8-b00]porphyrinato}copper(II) 13 (180 mg, 0.131 mmol)
in CH2Cl2 (90 ml) was stirred and heated at 100 1C with
trifluoroacetic acid (2 ml) and concentrated sulfuric acid (98%,
4.4 ml) for 3 days, then poured onto ice (50 g). When the ice
melted the organic phase was separated, washed with water
(200 ml), sodium carbonate solution (10%, 2 ꢃ 200 ml), water
(200 ml), dried over anhydrous sodium sulfate, filtered and the
filtrate evaporated to dryness. The crude mixture was purified
by chromatography over silica (CH2Cl2–light petroleum; 1 : 2)
to give two fractions. The first fraction gave 13-nitro-5,10,15,
20-tetrakis(3,5-di-tert-butylphenyl)bisquinoxalino[2,3-b0:7,8-b00]-
porphyrin 14a (28.0 mg, 16%) as a green microcrystalline
solid, mp 4 300 1C, which co-chromatographed with an
authentic sample prepared by method 1. The second fraction
gave 12-nitro-5,10,15,20-tetrakis(3,5-di-tert-butylphenyl)bis-
quinoxalino[2,3-b0:7,8-b00]porphyrin 14b (90.0 mg, 52%) as a
green microcrystalline solid, mp 4 300 1C, which co-chromato-
graphed with an authentic sample prepared by method 1.
12,13-Dioxo-5,10,15,20-tetrakis(3,5-di-tert-butylphenyl)bis-
quinoxalino[2,3-b0:7,8-b00]porphyrin 16. The above reactions
were repeated on 12- and 13-nitro-5,10,15,20-tetrakis(3,5-
di-tert-butylphenyl)bisquinoxalino[2,3-b0:7,8-b00]porphyrin 14
(48.4 mg, 0.0369 mmol) but without addition of 1,2-diamino-
benzene. The solvent was removed under vacuum and the
crude mixture was purified by column chromatography over
silica (CH2Cl2–light petroleum 2 : 3). The front running
orange band was collected and the solvent removed to
give 12,13-dioxo-5,10,15,20-tetrakis(3,5-di-tert-butylphenyl)-
bisquinoxalino[2,3-b0:7,8-b00]porphyrin 16 (15.2 mg, 32%) as
a black microcrystalline solid, mp 4 300 1C; (ESI-HRMS
found: [M + H]+ 1297.772. C88H97N8O2 requires 1297.773);
n
max(CHCl3)/cmꢂ1 3354w (NH), 2964s, 2903m, 2866m, 1724s
(CO), 1595m; lmax(CHCl3)/nm 352sh (loge 4.68), 404 (4.97),
464 (4.85), 530sh (4.47), 589sh (4.12), 684 (3.66), 710 (3.60),
760 (3.59); dH(400 MHz; CDCl3) 0.15 (1 H, br s, inner NH),
0.19 (1 H, br s, inner NH), 1.43 (18 H, s, t-butyl H), 1.44 (18 H,
s, t-butyl H), 1.47 (18 H, s, t-butyl H), 1.48 (18 H, s, t-butyl H),
7.65 (2 H, d, J 1.8 Hz, Ho), 7.70 (2 H, d, J 1.8 Hz, Ho),
7.71–7.93 (15 H, m, quinoxaline H, Ho, Hp), 8.00 (1 H, t,
J 1.8 Hz, Hp), 8.33 and 8.55 (2 H, d of ABq, J 4.7, JNH 1.9 Hz,
b-pyrrolic H); m/z (ESI) 1296.9 (M+ requires 1296.8).
5,10,15,20-Tetrakis(3,5-di-tert-butylphenyl)trisquinoxalino-
[2,3-b0:7,8-b00:12,13-b00 0]porphyrin 1. A solution of crude
12- and 13-nitro-5,10,15,20-tetrakis(3,5-di-tert-butylphenyl)-
bisquinoxalino[2,3-b0:7,8-b00]porphyrin 14 (0.593 g, 0.451 mmol)
in a HCl–ether mixture (4 M, 40 ml) was stirred with tin(II)
chloride dihydrate (0.441 g, 1.95 mmol) in the dark for 2 h.
Work-up as before gave 12- and 13-amino-5,10,15,20-tetra-
kis(3,5-di-tert-butylphenyl)bisquinoxalino[2,3-b0:7,8-b00]porphyrin
15. The mixture was dissolved in CH2Cl2 (2 L) and
photooxidised in the presence of 1,2-diaminobenzene (0.218 g,
Synthesis of trisquinoxalinoporphyrin 1 from metallated
linear bisquinoxalinoporphyrin (Pathway 2, Scheme 3)
2.02 mmol) for
5 h. Mass spectroscopy showed the
presence of 12,13-dioxo-5,10,15,20-tetrakis(3,5-di-tert-butyl-
phenyl)bisquinoxalino[2,3-b0:7,8-b00]porphyrin 16 as an inter-
mediate. The solvent was removed under vacuum and the
crude mixture purified by column chromatography over silica
(CH2Cl2–light petroleum 1 : 3). The first dark green band was
{7-Nitro-5,10,15,20-tetrakis(3,5-di-tert-butylphenyl)bisquin-
oxalino[2,3-b0:12,13-b00]porphyrinato}zinc(II) 18. {5,10,15,20-
Tetrakis(3,5-di-tert-butylphenyl)bisquinoxalino[2,3-b0:12,13-b00]-
porphyrinato}zinc(II)13
8 (60.0 mg, 0.0451 mmol) was
dissolved in CH2Cl2 (500 ml) and nitrated. The crude mixture
ꢀc
This journal is The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2009 New J. Chem., 2009, 33, 1076–1086 | 1083